SSG
Summit Securities Group Portfolio holdings
AUM
$280M
1-Year Return
13.47%
This Quarter Return
-0.08%
1 Year Return
+13.47%
3 Year Return
+33.41%
5 Year Return
+89.54%
10 Year Return
+225.55%
AUM
$144M
AUM Growth
-$124M
(-46%)
Cap. Flow
-$119M
Cap. Flow
% of AUM
-82.86%
Top 10 Holdings %
Top 10 Hldgs %
48.79%
Holding
1,004
New
477
Increased
73
Reduced
66
Closed
332
Top Buys
| 1 |
Apple
AAPL
|
+$19.1M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$10.6M |
| 3 |
ArcelorMittal
MT
|
+$3.78M |
| 4 |
STMicroelectronics
STM
|
+$3.26M |
| 5 |
Industrial Select Sector SPDR Fund
XLI
|
+$2.93M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$56.8M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$33.3M |
| 3 |
Utilities Select Sector SPDR Fund
XLU
|
+$10.1M |
| 4 |
Goldman Sachs
GS
|
+$8.36M |
| 5 |
Energy Transfer Partners
ET
|
+$7.98M |
Sector Composition
| 1 | Technology | 26.89% |
| 2 | Financials | 11.73% |
| 3 | Consumer Staples | 9.84% |
| 4 | Healthcare | 7.74% |
| 5 | Consumer Discretionary | 5.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
Udemy
UDMY
$1.03B
| $2.38K | ﹤0.01% |
+306
| New | +$2.38K |
|
527
G-III Apparel Group
GIII
$1.14B
| $2.35K | ﹤0.01% |
+86
| New | +$2.35K |
|
528
Ardelyx
ARDX
$1.58B
| $2.35K | ﹤0.01% |
+478
| New | +$2.35K |
|
529
CommScope
COMM
$3.59B
| $2.35K | ﹤0.01% |
+442
| New | +$2.35K |
|
530
Viridian Therapeutics
VRDN
$1.65B
| $2.35K | ﹤0.01% |
+174
| New | +$2.35K |
|
531
Innodata
INOD
$1.71B
| $2.33K | ﹤0.01% |
+65
| New | +$2.33K |
|
532
Establishment Labs
ESTA
$1.14B
| $2.33K | ﹤0.01% |
+57
| New | +$2.33K |
|
533
Spyre Therapeutics
SYRE
$1.01B
| $2.15K | ﹤0.01% |
+133
| New | +$2.15K |
|
534
RxSight
RXST
$400M
| $2.12K | ﹤0.01% |
+84
| New | +$2.12K |
|
535
FS KKR Capital
FSK
$5B
| $2.1K | ﹤0.01% |
100
-2,700
| -96% | -$56.6K |
|
536
Sinclair Inc
SBGI
$942M
| $2.06K | ﹤0.01% |
+129
| New | +$2.06K |
|
537
First Watch Restaurant Group
FWRG
$1.06B
| $2.03K | ﹤0.01% |
+122
| New | +$2.03K |
|
538
Fox Factory Holding Corp
FOXF
$1.21B
| $2.01K | ﹤0.01% |
+86
| New | +$2.01K |
|
539
Nurix Therapeutics
NRIX
$703M
| $1.84K | ﹤0.01% |
+155
| New | +$1.84K |
|
540
Cracker Barrel
CBRL
$1.12B
| $1.75K | ﹤0.01% |
+45
| New | +$1.75K |
|
541
Krispy Kreme
DNUT
$531M
| $1.69K | ﹤0.01% |
+344
| New | +$1.69K |
|
542
XPEL
XPEL
$1.03B
| $1.68K | ﹤0.01% |
+57
| New | +$1.68K |
|
543
Myriad Genetics
MYGN
$649M
| $1.61K | ﹤0.01% |
+181
| New | +$1.61K |
|
544
BlackRock TCP Capital
TCPC
$611M
| $1.56K | ﹤0.01% |
+195
| New | +$1.56K |
|
545
Ichor Holdings
ICHR
$563M
| $1.56K | ﹤0.01% |
+69
| New | +$1.56K |
|
546
Maxeon Solar Technologies
MAXN
$67.6M
| $1.52K | ﹤0.01% |
516
+490
| +1,885% | +$1.45K |
|
547
Praxis Precision Medicines
PRAX
$843M
| $1.52K | ﹤0.01% |
+40
| New | +$1.52K |
|
548
Liberty Latin America Class C
LILAK
$1.57B
| $1.51K | ﹤0.01% |
+243
| New | +$1.51K |
|
549
Enliven Therapeutics
ELVN
$1.17B
| $1.5K | ﹤0.01% |
+76
| New | +$1.5K |
|
550
Fortrea Holdings
FTRE
$914M
| $1.44K | ﹤0.01% |
191
-10,809
| -98% | -$81.6K |
|